Jaguar Health, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on August 28, 2018. The Company, an emerging growth company, reported the entry into a material definitive agreement regarding its office lease and a related financing arrangement.
Key Financial Metrics and Agreements
The filing details a new Office Lease Agreement and a Letter of Credit arrangement rather than standard periodic financial results.
- Office Lease: Extension for approximately 6,311 square feet at 201 Mission Street, San Francisco, CA.
- Lease Term: September 1, 2018, to September 30, 2020.
- Base Rent:
- Months 1-12: $38,391.92 per month.
- Months 13-24: $39,543.67 per month.
- Month 25: $40,729.98.
- Letter of Credit (LOC): A $475,000 LOC was issued by Pacific Capital Management, LLC (an existing shareholder) to secure the lease.
- Warrant Issuance: In consideration for the LOC, the Company issued a five-year warrant to purchase 670,586 shares of common stock.
- Warrant Terms:
- Exercise Price: Lower of $0.85 per share or the 30-day average closing price starting September 4, 2018.
- Commencement: Exercisable after a 7-month anniversary from issuance.
Material Changes and Conditions
The filing outlines specific conditions for the release or reduction of the shareholder's exposure under the Letter of Credit:
- Full Release Condition: The LOC must be replaced by a non-shareholder guaranteed LOC within 10 business days of the Company receiving $6 million in unrestricted cash from business development transactions (excluding Mytesi revenues, debt repayments, or equity sales) or by the one-year anniversary of the warrant issuance, whichever is earlier.
- Partial Reduction Condition: If the Company has not received at least $5 million in gross proceeds from any source (debt or equity) by October 1, 2018, the shareholder's exposure must be reduced by $122,000 within 10 business days thereafter.
Outlook, Risks, and Management Commentary
The filing does not provide general business outlook or management commentary beyond the specific terms of the lease and warrant. The primary risk identified is the Company's reliance on a shareholder to secure its primary office lease, contingent upon the Company's ability to raise capital or generate specific cash flows to replace the shareholder's guarantee.
Key Facts for Investor Verification
- Verify the Company's progress toward raising the $5 million or $6 million thresholds required to release the shareholder's $475,000 guarantee.
- Monitor the stock price relative to the $0.85 warrant exercise price cap.
- Confirm the status of the lease extension and any potential termination clauses.
- Review the full text of the Warrant and LOC Agreement (Exhibits 4.1 and 10.2) for additional covenants not summarized here.